Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhongxing Liao

Showing results (1-10 of 439) with videos related to

Pageof 44
Sort By:
Journal of Thoracic Disease|October 30, 2018
Considerations in randomized trials to test technologiesZhongxing Liao
The British Journal of Radiology|August 21, 2019
Proton therapy for locally advanced non-small cell lung cancerOlsi Gjyshi, Zhongxing Liao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Future of Protons Depends on PrecisionZhongxing Liao, Radhe Mohan
Expert Review of Anticancer Therapy|July 24, 2004
COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancerZhongxing Liao, Luka Milas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Reply to R. Rengan et alZhongxing Liao, Radhe Mohan
Translational Lung Cancer Research|June 8, 2018
Particle therapy in non-small cell lung cancerZhongxing Liao, Charles B Simone
Seminars in Oncology|February 26, 2004
Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancerRitsuko Komaki, Zhongxing Liao, Luka Milas
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
Radiochemotherapy of esophageal cancerZhongxing Liao, James D Cox, Ritsuko Komaki
Drugs|April 13, 2007
Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?Zhongxing Liao, Kathryn A Mason, Luka Milas
Expert Review of Anticancer Therapy|June 19, 2013
β-Blockers and metastasis in non-small-cell lung cancerHongmei Wang, Daniel R Gomez, Zhongxing Liao
Pageof 44

Showing results (1-10 of 439) with videos related to

Sort By:
Pageof 44
Journal of Thoracic Disease|October 30, 2018
Considerations in randomized trials to test technologiesZhongxing Liao
The British Journal of Radiology|August 21, 2019
Proton therapy for locally advanced non-small cell lung cancerOlsi Gjyshi, Zhongxing Liao
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Future of Protons Depends on PrecisionZhongxing Liao, Radhe Mohan
Expert Review of Anticancer Therapy|July 24, 2004
COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancerZhongxing Liao, Luka Milas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Reply to R. Rengan et alZhongxing Liao, Radhe Mohan
Translational Lung Cancer Research|June 8, 2018
Particle therapy in non-small cell lung cancerZhongxing Liao, Charles B Simone
Seminars in Oncology|February 26, 2004
Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancerRitsuko Komaki, Zhongxing Liao, Luka Milas
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
Radiochemotherapy of esophageal cancerZhongxing Liao, James D Cox, Ritsuko Komaki
Drugs|April 13, 2007
Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?Zhongxing Liao, Kathryn A Mason, Luka Milas
Expert Review of Anticancer Therapy|June 19, 2013
β-Blockers and metastasis in non-small-cell lung cancerHongmei Wang, Daniel R Gomez, Zhongxing Liao
Pageof 44